⌘K
Loading ticker…
As of 2026-08-24, X4 Pharmaceuticals, Inc. Common Stock (XFOR) has a 3-month relative strength percentile of 49 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 53. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.1%, relative volume 0.40×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
XFOR is held by 3 ETFs as of May 2026. Top owner: AVSC at 0.01% weight, $201K notional. Top 3 carry $201K.
Held by 6 ETFs · $14M across latest filings · largest weight 0.01% (AVSC).
Top 3 by value, from SEC N-PORT-P filings dated May 2026.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | XFOR Jan avg: -3.79% median: -5.69% win: 25% σ: 5.16% n: 4 2022-04-12 → 2026-07-31 | XFOR Feb avg: -8.83% median: -7.98% win: 25% σ: 27.70% n: 4 2022-04-12 → 2026-07-31 | XFOR Mar avg: 3.96% median: 6.40% win: 50% σ: 35.93% n: 4 2022-04-12 → 2026-07-31 | XFOR Apr avg: -2.10% median: -19.38% win: 20% σ: 41.92% n: 5 2022-04-12 → 2026-07-31 | XFOR May avg: 1.37% median: -6.20% win: 40% σ: 22.68% n: 5 2022-04-12 → 2026-07-31 | XFOR Jun avg: -20.60% median: -20.25% win: 20% σ: 23.11% n: 5 2022-04-12 → 2026-07-31 | XFOR Jul avg: 7.30% median: -7.73% win: 40% σ: 25.75% n: 5 2022-04-12 → 2026-07-31 | XFOR Aug avg: 14.96% median: -17.58% win: 25% σ: 72.67% n: 4 2022-04-12 → 2026-07-31 (current) | XFOR Sep avg: 11.14% median: -6.65% win: 25% σ: 41.27% n: 4 2022-04-12 → 2026-07-31 | XFOR Oct avg: -5.65% median: -7.08% win: 50% σ: 23.58% n: 4 2022-04-12 → 2026-07-31 | XFOR Nov avg: -13.74% median: -15.48% win: 0% σ: 9.17% n: 4 2022-04-12 → 2026-07-31 | XFOR Dec avg: 17.56% median: 8.70% win: 75% σ: 50.24% n: 4 2022-04-12 → 2026-07-31 |